Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules

被引:5
|
作者
D'Andrea, Gregoire [1 ]
Gal, Jocelyn [2 ]
Mandine, Loic [2 ]
Dassonville, Olivier [1 ]
Vandersteen, Clair [1 ]
Guevara, Nicolas [1 ]
Castillo, Laurent [1 ]
Poissonnet, Gilles [1 ]
Culie, Dorian [1 ]
Elaldi, Roxane [1 ]
Sarini, Jerome [3 ]
Decotte, Anne [4 ]
Renaud, Claire [5 ]
Vergez, Sebastien [3 ,4 ]
Schiappa, Renaud [2 ]
Chamorey, Emmanuel [2 ]
Chateau, Yann [2 ]
Bozec, Alexandre [1 ]
机构
[1] Cote Azur Univ, GHS Nice Univ Hosp, Inst Univ Face & Cou, Antoine Lacassagne Ctr,Otorhinolaryngol & Head &, F-06103 Nice, France
[2] Ctr Antoine Lacassagne, Dept Stat, F-06103 Nice, France
[3] Univ Canc Inst Toulouse Oncopole, Otorhinolaryngol & Head & Neck Surg Dept, F-31400 Toulouse, France
[4] Hop Larrey, Toulouse Univ Hosp, Otorhinolaryngol & Head & Neck Surg Dept, F-31400 Toulouse, France
[5] Hop Larrey, Toulouse Univ Hosp, Thorac Surg Dept, F-31400 Toulouse, France
关键词
thyroid nodules; risk of malignancy; thyroid cancer; cytopathological features; ultrasonographic features; machine learning; predictive model; PPAR-GAMMA/RXR-ALPHA; ASSOCIATION GUIDELINES; CANCER-RISK; DIABETES-MELLITUS; SYSTEM; DIAGNOSIS; HETERODIMERS; MUTATIONS; RECEPTORS; VARIANTS;
D O I
10.1093/ejendo/lvad017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Indeterminate thyroid nodules (ITN) are common and often lead to (sometimes unnecessary) diagnostic surgery. We aimed to evaluate the performance of two machine learning methods (ML), based on routinely available features to predict the risk of malignancy (RM) of ITN. Design Multi-centric diagnostic retrospective cohort study conducted between 2010 and 2020. Methods Adult patients who underwent surgery for at least one Bethesda III-V thyroid nodule (TN) with fully available medical records were included. Of the 7917 records reviewed, eligibility criteria were met in 1288 patients with 1335 TN. Patients were divided into training (940 TN) and validation cohort (395 TN). The diagnostic performance of a multivariate logistic regression model (LR) and its nomogram, and a random forest model (RF) in predicting the nature and RM of a TN were evaluated. All available clinical, biological, ultrasound, and cytological data of the patients were collected and used to construct the two algorithms. Results There were 253 (19%), 693 (52%), and 389 (29%) TN classified as Bethesda III, IV, and V, respectively, with an overall RM of 35%. Both cohorts were well-balanced for baseline characteristics. Both models were validated on the validation cohort, with performances in terms of specificity, sensitivity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve of 90%, 57.3%, 73.4%, 81.4%, 84% (CI95%: 78.5%-89.5%) for the LR model, and 87.6%, 54.7%, 68.1%, 80%, 82.6% (CI95%: 77.4%-87.9%) for the RF model, respectively. Conclusions Our ML models performed well in predicting the nature of Bethesda III-V TN. In addition, our freely available online nomogram helped to refine the RM, identifying low-risk TN that may benefit from surveillance in up to a third of ITN, and thus may reduce the number of unnecessary surgeries.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 37 条
  • [1] Association of patient characteristics, ultrasound features, and molecular testing with malignancy risk in Bethesda III-V thyroid nodules
    Talmor, Guy
    Badash, Ido
    Zhou, Sheng
    Kim, Yun Ji
    Kokot, Niels C.
    Hsueh, Wayne
    Chambers, Tamara
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2022, 7 (04): : 1243 - 1250
  • [2] Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review
    Rao, Karthik Nagaraja
    Randolph, Gregory W.
    Lopez, Fernando
    Zafereo, Mark
    Coca-Pelaz, Andres
    Piazza, Cesare
    Dange, Prajwal
    Rodrigo, Juan Pablo
    Stenman, Goeran
    de Keizer, Bart
    Nixon, Iain
    Sinha, Shriyash
    Leboulleux, Sophie
    Maekitie, Antti A.
    Agaimy, Abbas
    Thompson, Lester
    Ferlito, Alfio
    ENDOCRINE, 2024, 85 (02) : 473 - 492
  • [3] Prediction of Malignancy in Bethesda Category III Nodules: Application of Thyroid Imaging Reporting System
    Senol, Kazim
    Katar, Kagan
    Yuksel, Cemil
    Saylam, Baris
    Tez, Mesut
    AMERICAN SURGEON, 2015, 81 (11) : E351 - E352
  • [4] Diagnostic models for predicting malignancy in thyroid nodules classified as Bethesda Category III in an endemic region
    Kasap, Zeliha Aydin
    Kurt, Burcin
    Ozsagir, Elif
    Ercin, Mustafa Emre
    Guner, Ali
    DIAGNOSTIC CYTOPATHOLOGY, 2024, 52 (04) : 200 - 210
  • [5] Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy
    Walters, Benjamin K.
    Garrett, Samuel L.
    Aden, James K.
    Williams, Grant M.
    Butler-Garcia, Samantha L.
    Newberry, Travis R.
    Mckinlay, Alex J.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2021, 130 (09): : 1064 - 1068
  • [6] Comments on "diagnostic models for predicting malignancy in thyroid nodules classified as Bethesda category III in an endemic region"
    Goel, Archit
    Kapatia, Gargi
    Gupta, Shruti
    Gupta, Vikasdeep
    Sidana, Shivani
    DIAGNOSTIC CYTOPATHOLOGY, 2024, 52 (05) : 288 - 289
  • [7] Clinical Risk Score for Malignancy in Surgical Patients with Indeterminate Bethesda III and IV Thyroid Nodules
    Farra, J. C.
    Yakoub, D.
    Rubio, G. A.
    Zhao, W.
    Tulay, K.
    Lew, J. I.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S35 - S36
  • [8] Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan, Colleen M.
    Solorzano, Carmen C.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (01) : 77 - 82
  • [9] Respond to "Comments on 'Diagnostic models for predicting malignancy in thyroid nodules classified as Bethesda category III in an endemic region'"
    Kasap, Zeliha Aydin
    Kurt, Burcin
    Ozsagir, Elif
    Ercin, Mustafa Emre
    Guner, Ali
    DIAGNOSTIC CYTOPATHOLOGY, 2024, 52 (05) : 290 - 291
  • [10] The gray zone of thyroid nodules: Using a nomogram to provide malignancy risk assessment and guide patient management
    Yousefi, Elham
    Sura, Gloria H.
    Somma, Jonathan
    CANCER MEDICINE, 2021, 10 (08): : 2723 - 2731